TMEM97 and pancreatic neoplasm: Multiple structurally distinct compounds (Fig. 1) with high affinity for sigma-2 receptors (Table 1) were tested for cytotoxicity against multiple pancreatic cancer cell lines in vitro (Table 1) and screened for efficacy in a mouse model of pancreatic cancer with Panc02 cells.